Dale turned the light out and went back to sleep, even without his Prozac and flurazepam and doxepin.    From Wordnik.com.  [A Winter Haunting]

“But I only take the doxepin and flurazepam to sleep and it was about time to wean myself from the Prozac anyway.”.    From Wordnik.com.  [A Winter Haunting]

The current nightcap, as it were, is 50 mg doxepin, followed in one hour by 10 mg zolpidem this is the non-CR version of Ambien.    From Wordnik.com.  [dustbury.com » Snooze on the hour] Reference

(NDA) for Silenor® (doxepin) for the treatment of insomnia.    From Wordnik.com.  [Health News from Medical News Today] Reference

(NDA) to the FDA for Silenor (doxepin) for the treatment of insomnia in response to a.    From Wordnik.com.  [SeekingAlpha.com: Home Page] Reference

A post mortem examination showed she had died from an overdose of doxepin and salicylate.    From Wordnik.com.  [Latest Isle of Wight News] Reference

Silenor is a low-dose formulation of the antidepressant doxepin, which has been in use for.    From Wordnik.com.  [Fore, right!] Reference

Talk with your sinequan doxepin if your metals do never wean after 4 situations of treatment.    From Wordnik.com.  [Wii-volution] Reference

Silenor is an oral tablet formulation of doxepin at strengths of three milligram and six milligram.    From Wordnik.com.  [The Earth Times Online Newspaper] Reference

(R) (doxepin), which Somaxon launched in September 2010 with its co-promotion partner Procter & Gamble.    From Wordnik.com.  [Somaxon Pharmaceuticals, Inc. (SOMX) President and Chief Executive Officer to Ring the NASDAQ Stock Market Opening Bell - Yahoo! Finance] Reference

Somaxon has submitted a New Drug Application for its product candidate, Silenor® (doxepin), to the U.S.    From Wordnik.com. Reference

Silenor® (doxepin) is a sleep-specific, low-dose, oral tablet formulation of doxepin for use in insomnia.    From Wordnik.com.  [Biotech Sector and Stocks Analysis from Seeking Alpha] Reference

FDA on January 20, 2010 to discuss the New Drug Application for Silenor (doxepin) for the treatment of insomnia.    From Wordnik.com.  [StreetInsider.com News Articles] Reference

(FDA) on January 20, 2010 to discuss the New Drug Application (NDA) for Silenor (doxepin) for the treatment of insomnia.    From Wordnik.com.  [StreetInsider.com News Articles] Reference

A New Drug Application (NDA) for Silenor® (doxepin), Somaxon's drug candidate for insomnia, has been filed with the U.S.    From Wordnik.com.  [The Earth Times Online Newspaper] Reference

Silenor is a low-dose (3 mg, 6 mg) oral tablet formulation of doxepin hydrochloride that is patent protected for use in insomnia.    From Wordnik.com.  [Health News from Medical News Today] Reference

Physicians have prescribed doxepin for more than 35 years for the treatment of depression and anxiety at dosages typically ranging from 75 mg to.    From Wordnik.com.  [BioSpace.com Featured News] Reference

Physicians have prescribed doxepin for more than 35 years for the treatment of anxiety at dosages typically ranging from 75 mg to 300 mg per day.    From Wordnik.com.  [Health News from Medical News Today] Reference

It also includes the results of the Company's completed clinical trial of doxepin that evaluated the potential for electrocardiogram (ECG) effects.    From Wordnik.com.  [SeekingAlpha.com: Home Page] Reference

FDA has approved the New Drug Application for Silenor® (doxepin) for the treatment of insomnia characterized by difficulty with sleep maintenance.    From Wordnik.com.  [StreetInsider.com News Articles] Reference

Somaxon's product Silenor® (doxepin) has been approved by the FDA for the treatment of insomnia characterized by difficulty with sleep maintenance.    From Wordnik.com.  [The Earth Times Online Newspaper] Reference

Its principal product Silenor doxepin has been approved by the FDA for the treatment of insomnia characterized by difficulty with sleep maintenance.    From Wordnik.com.  [Somaxon: A Bargain Buy Pharma -- Seeking Alpha] Reference

Somaxon responded by submitting to the FDA the results of its completed clinical trial of doxepin that evaluated the potential for electrocardiogram, or ECG, effects.    From Wordnik.com.  [Digital50.com Digital 50 Daily Industry News RSS Feed] Reference

Somaxon Announces FDA Approval of Silenor (R) (doxepin) for the Treatment of Insomnia seniors need more of than younger adults, is great to get a bit of in the middle of the day and could cause.    From Wordnik.com.  [WN.com - Articles related to Sleep your way to health and happiness] Reference

With respect to safety, the FDA noted that there were no adverse events observed that would preclude approval, but asked the company to address the possibility that doxepin may prolong the cardiac QT interval.    From Wordnik.com.  [Digital50.com Digital 50 Daily Industry News RSS Feed] Reference

(doxepin) rests with the Food and Drug Administration.    From Wordnik.com.  [10Q Detective] Reference

® (doxepin), Somaxon's drug candidate for insomnia, has been filed with the U.S.    From Wordnik.com.  [IBTimes.com RSS Feed - Politics & Policy] Reference

Somaxon Announces FDA Approval of Silenor (R) (doxepin) for the Treatment of Insomnia.    From Wordnik.com.  [WN.com - Business News] Reference

Fairmont hot springs baked two doxepin of branchiura rancor disapproval, i vestrywoman two enrollee from a red akc merged mom.    From Wordnik.com.  [Rational Review] Reference

Prozac and flurazepam and doxepin.    From Wordnik.com.  [A Winter Haunting]

Weight loss on doxepin.    From Wordnik.com.  [quotes « WordPress.com Tag Feed] Reference

2 / 25 / 09) for insomnia drug Silenor (doxepin) following a meeting with the FDA Division of Neurology Products on the previous day.    From Wordnik.com.  [Japan Stocks News and Analysis from Seeking Alpha] Reference